Cipla doubles remdesivir production to meet 'unprecedented' demand – Reuters

Cipla doubles remdesivir production to meet ‘unprecedented’ demand – Reuters

India’s Cipla Ltd has doubled production of COVID-19 medication remdesivir to help meet “unprecedented demand” as the country battles a massive second wave of infections, the drugmaker said on Tuesday.

Read More…

You May Also Like